ARTICLE SUMMARY:
In this month’s spotlight from Pathways’ Document Depot: a case study published by the Medical Device Innovation Consortium and AppliedVR from the virtual reality firm’s success in treading a new reimbursement path for digital therapeutics.
Docs of the Month is a regular column highlighting key findings from Pathways’ Document Depot, a database of global medtech regulatory and policy official documents, including rules, guidance documents, memos, white papers, and more from national authorities, non-governmental groups, and global organizations.
Many of the items we track in Document Depot establish or explain new medtech policies from the perspective of government agencies. But a subset of the materials aim to go a step further in illustrating how product developers can apply the policies in the real world.
The Medical Device Innovation Consortium (MDIC) is an important resource for these latter types of items. MDIC is a public-private partnership bringing together FDA and other government agencies, device companies, clinical researchers, and others. As part of its work, it generates how-to documents, including case studies, tied to specific regulatory and reimbursement policies for medtech firms. In February, MDIC, partnering with the virtual reality device firm AppliedVR, published an interesting case study addressing the hot topic of reimbursement for digital therapeutic devices. The paper, one of 31 documents captured in Depot last month (see infographic), is Market Pathways’ latest Doc of the Month.
